Skip to main content

Aadi Bioscience

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20221
Download CSV

FDA Recall Terminated Historical recordClass III

Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.

by Aadi Bioscience

Reason
Failed Stability Specifications
Published
November 23, 2022
Distribution
Within the U.S Market - PA, AL, KY, TN

View recall →

Showing 1–1 of 1 results

This page lists recalls that name Aadi Bioscience as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.